The 3rd International Oncology Conference

26/4/2017

The conference, held 2 months prior to the planned inauguration of the new Radiotherapy Unit in Ziv, was organized in cooperation with the Faculty of Medicine,the Israeli Society for Clinical Oncology and the Israel Cancer Association.

According to Professor Jamal Zidan, Head of the Oncology Institute in Ziv and initiator of the conference, the lectures were of the highest standard, encompassing a wide range of issues and including the most up-to-date research. Among the lecturers participating was Professor Yosef Yarden, a member of the the Israel Academy of Sciences and Humanities and Head of the Department of Biological Regulation at the Weizmann Institute of Science; the internationally acclaimed geneticist, Professor Harry Ostrer of the Albert Einstein College of Medicine in New York; Professor Eitan Friedman, founder and director of the Oncogenetics Unit of Sheba Medical Center, Tel Hashomer; Professor Ran Tur-Kaspa, Dean of the Bar-Ilan University Faculty of Medicine in the Galilee and researcher in the field of the hepatitis viruses and liver diseases; Dr. Joseph Rosenblatt of the University of Miami Miller School of Medicine specializing in hematology and oncology; Professor Jonathan Ledermann of University College Hospital, London, an  international expert in gynecological cancers such as ovarian cancer.

The conference which dealt with the future of oncology treatment focused specifically on Molecular Targeted Therapy. These advanced treatments are a result of thousands of research studies, both past and present, of leading international oncology institutes on the molecular biology of the cancer infected cells. The international oncology conference provided an opportunity for the exchange of information and for cooperation between Israeli and international researchers and institutes.

A surprise to all was when Professor Jamal Zidan interrupted the conference to congratulate Professor Yosef Yarden with a bouquet of flowers, in honor of his being awarded the Israel Prize in Life Sciences 2017. Professor Yarden, known for his modesty, was very touched by the tribute in front of the many Israeli and foreign medical practitioners and researchers present at the international conference. Professor Yarden lectured at the conference on his breakthrough discoveries in the field of the biochemistry of cancer, for which he received the most prestigious prize Israel has to offer. He spoke as well about the challenges of the future to develop molecular targeted drugs for cancer treatment.